Nasus Pharma to present NS002 intranasal epinephrine study results

March 9, 2026 8:30 AM

Nasus Pharma Ltd. (NYSE: NSRX) announced it will host a conference call on March 16, 2026, at 8:00 a.m. ET ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found